Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1977 Sep 3;2(6087):610–611. doi: 10.1136/bmj.2.6087.610

Metronidazole neuropathy.

W G Bradley, I J Karlsson, C G Rassol
PMCID: PMC1631560  PMID: 198056

Full text

PDF
610

Images in this article

611p611-a
on p.611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E., Dische S., Fowler J. F., Thomlinson R. H. Hypoxic cell sensitisers in radiotherapy. Lancet. 1976 Jan 24;1(7952):186–188. doi: 10.1016/s0140-6736(76)91285-x. [DOI] [PubMed] [Google Scholar]
  2. Berget A., Weber T. Metronidazol og graviditet. Ugeskr Laeger. 1972 Oct 2;134(40):2085–2089. [PubMed] [Google Scholar]
  3. Carne S. Letter: Metronidazole and acne. Lancet. 1976 Aug 14;2(7981):367–367. doi: 10.1016/s0140-6736(76)92622-2. [DOI] [PubMed] [Google Scholar]
  4. Coxon A., Pallis C. A. Metronidazole neuropathy. J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):403–405. doi: 10.1136/jnnp.39.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodwin D. W., Reinhard J. Disulfiramlike effects of trichomonacidal drugs. A review and double-blind study. Q J Stud Alcohol. 1972 Sep;33(3):734–740. [PubMed] [Google Scholar]
  6. Ings R. M., McFadzean J. A., Ormerod W. E. The fate of metronidazole and tis implications in chemotherapy. Xenobiotica. 1975 Apr;5(4):223–235. doi: 10.3109/00498257509052069. [DOI] [PubMed] [Google Scholar]
  7. Ings R. M., McFadzean J. A., Ormerod W. E. The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochem Pharmacol. 1974 May 1;23(9):1421–1429. doi: 10.1016/0006-2952(74)90362-1. [DOI] [PubMed] [Google Scholar]
  8. Kind A. C., Kestle D. G., Standiford H. C., Freeman P., Kirby W. M. Development of staphylococci cross-resistant to cephalexin and methicillin. Antimicrob Agents Chemother (Bethesda) 1968;8:405–409. [PubMed] [Google Scholar]
  9. Placidi G. F., Masuoka D., Alcaraz A., Taylor J. A., Earle R. Distribution and metabolism of 14C-metronidazole in mice. Arch Int Pharmacodyn Ther. 1970 Nov;188(1):168–179. [PubMed] [Google Scholar]
  10. Pye R. J., Burton J. L. Treatment of rosacea by metronidazole. Lancet. 1976 Jun 5;1(7971):1211–1212. doi: 10.1016/s0140-6736(76)92160-7. [DOI] [PubMed] [Google Scholar]
  11. Ramsay I. D. Endocrine ophthalmopathy. Br Med J. 1968 Dec 14;4(5632):706–706. doi: 10.1136/bmj.4.5632.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Robinson S. C., Mirchandani G. Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant follow-up). Am J Obstet Gynecol. 1965 Oct 15;93(4):502–505. [PubMed] [Google Scholar]
  13. Rustia M., Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst. 1972 Mar;48(3):721–729. [PubMed] [Google Scholar]
  14. Sutherland R. M. Selective chemotherapy of noncycling cells in an in vitro tumor model. Cancer Res. 1974 Dec;34(12):3501–3503. [PubMed] [Google Scholar]
  15. Tanga M. R., Antani J. A., Kabade S. S. Clinical evaluation of metronidazole as an anti-inflammatory agent. Int Surg. 1975 Feb;60(2):75–76. [PubMed] [Google Scholar]
  16. Ursing B., Kamme C. Metronidazole for Crohn's disease. Lancet. 1975 Apr 5;1(7910):775–777. doi: 10.1016/s0140-6736(75)92438-1. [DOI] [PubMed] [Google Scholar]
  17. Voogd C. E., Van der Stel J. J., Jacobs J. J. The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole. Mutat Res. 1974 Dec;26(6):483–490. doi: 10.1016/s0027-5107(74)80049-7. [DOI] [PubMed] [Google Scholar]
  18. Wyburn-Mason R. Letter: Clotrimazole and rheumatoid arthritis. Lancet. 1976 Feb 28;1(7957):489–489. doi: 10.1016/s0140-6736(76)91516-6. [DOI] [PubMed] [Google Scholar]
  19. von Rogulja P., Kovac W., Schmid H. Metronidazol-Encephalopathie der Ratte. Acta Neuropathol. 1973 Jun 26;25(1):36–45. doi: 10.1007/BF00686856. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES